MYGN ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Myriad Genetics, Inc. Shareholders Who Lost Money
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. for potential federal securities law violations. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test from January 2025.
November 11, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Myriad Genetics is under investigation for potential securities law violations after UnitedHealth announced it will stop covering GeneSight, a key product, from January 2025.
The investigation by Levi & Korsinsky could lead to legal challenges for Myriad Genetics, potentially affecting investor confidence. The loss of coverage by UnitedHealth for GeneSight, a significant product, may impact Myriad's revenues and market perception negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100